Danimer Scientific Inc
NYSE:DNMR
Danimer Scientific Inc
NYSE:DNMR
Price:
0.7512 USD
-4.89%
Market Closed
Updated:
May 10, 2024
Balance Sheet
Balance Sheet Decomposition
Danimer Scientific Inc
Danimer Scientific Inc
| Current Assets | 108m |
| Cash & Short-Term Investments | 59.2m |
| Receivables | 18.9m |
| Other Current Assets | 30m |
| Non-Current Assets | 590.1m |
| PP&E | 464.3m |
| Intangibles | 77.8m |
| Other Non-Current Assets | 48m |
| Current Liabilities | 15.7m |
| Accounts Payable | 5.3m |
| Accrued Liabilities | 7.5m |
| Other Current Liabilities | 2.9m |
| Non-Current Liabilities | 404.4m |
| Long-Term Debt | 381.4m |
| Other Non-Current Liabilities | 23m |
Balance Sheet
Danimer Scientific Inc
Danimer Scientific Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
378
|
287
|
63
|
59
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
378
|
287
|
63
|
59
|
|
| Total Receivables |
0
|
8
|
25
|
24
|
19
|
|
| Accounts Receivables |
0
|
8
|
21
|
23
|
18
|
|
| Other Receivables |
0
|
0
|
4
|
2
|
1
|
|
| Inventory |
0
|
14
|
25
|
33
|
25
|
|
| Other Current Assets |
0
|
3
|
5
|
5
|
5
|
|
| Total Current Assets |
0
|
402
|
340
|
125
|
108
|
|
| PP&E Net |
0
|
126
|
335
|
473
|
464
|
|
| PP&E Gross |
0
|
126
|
335
|
473
|
464
|
|
| Accumulated Depreciation |
0
|
20
|
29
|
45
|
70
|
|
| Intangible Assets |
0
|
2
|
85
|
81
|
78
|
|
| Goodwill |
0
|
0
|
63
|
0
|
0
|
|
| Note Receivable |
0
|
13
|
13
|
31
|
31
|
|
| Other Long-Term Assets |
0
|
2
|
2
|
2
|
17
|
|
| Other Assets |
0
|
0
|
63
|
0
|
0
|
|
| Total Assets |
0
N/A
|
546
+546 100%
|
839
+54%
|
712
-15%
|
698
-2%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
11
|
21
|
15
|
5
|
|
| Accrued Liabilities |
0
|
12
|
22
|
8
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
25
|
0
|
2
|
1
|
|
| Other Current Liabilities |
0
|
3
|
0
|
1
|
2
|
|
| Total Current Liabilities |
0
|
51
|
44
|
25
|
16
|
|
| Long-Term Debt |
0
|
31
|
261
|
286
|
381
|
|
| Deferred Income Tax |
0
|
0
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
108
|
33
|
23
|
23
|
|
| Total Liabilities |
0
N/A
|
190
+190 100%
|
338
+78%
|
335
-1%
|
420
+26%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
59
|
119
|
299
|
454
|
|
| Additional Paid In Capital |
0
|
415
|
619
|
676
|
732
|
|
| Total Equity |
0
N/A
|
356
N/A
|
500
+41%
|
378
-25%
|
278
-26%
|
|
| Total Liabilities & Equity |
0
N/A
|
546
+546 100%
|
839
+54%
|
712
-15%
|
698
-2%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
25
|
85
|
101
|
102
|
103
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
